The Seventh Circuit Court of Appeals ruled on July 28, 2026, in the case of Holli Carter v. Mead Johnson & Company LLC (Docket No. 25-2323), reversing a lower court's decision regarding fraudulent joinder. This ruling impacts several plaintiffs, including Holli Carter, who allege that their premature infants developed serious health issues after being fed cow's milk-based formula. The court's decision clarifies the standards for determining fraudulent joinder, which can significantly affect the jurisdiction of cases involving diverse parties.
The case stems from a larger group of lawsuits against Mead Johnson and Abbott Laboratories, manufacturers of infant formula products. The plaintiffs, who are parents of premature infants, claim that their children developed necrotizing enterocolitis (NEC), a severe gastrointestinal disorder, after consuming these formulas. The case is part of a multidistrict litigation (MDL) proceeding in the Northern District of Illinois, where many similar cases have been consolidated.
The plaintiffs originally filed their lawsuits in Pennsylvania state court but faced challenges when the defendants removed the cases to federal court. The lower court initially ruled that it lacked jurisdiction due to the presence of non-diverse defendants, specifically Pennsylvania Hospital, which was alleged to have failed to warn about the risks associated with the formula. However, the court later reversed this decision, leading to the appeal.
Background
The plaintiffs in this case include Holli Carter, Terraine Abdullah, Shondera Drayton, Gina Wieger, and Alice Stills, all of whom are parents of infants born prematurely at Pennsylvania Hospital. Each child was fed cow's milk-based formula produced by Mead Johnson or Abbott during their hospital stay, leading to serious health complications. The parents allege that the hospital failed to inform them of the risks associated with these products.
The cases were initially filed in Pennsylvania state court on March 24, 2022, and were subsequently removed to federal court. The defendants argued that the non-diverse parties were fraudulently joined, which would allow the case to remain in federal court despite the plaintiffs' claims against them. The lower court initially agreed with the plaintiffs, stating that they had a reasonable possibility of success against Pennsylvania Hospital, but later reversed its decision, leading to the appeal.
The Ruling
The Seventh Circuit, led by Judge Ripple, ruled that the lower court's approach to determining fraudulent joinder was inconsistent with established case law. The court stated, "The district court's view of the fraudulent joinder doctrine is not consistent with the case law of the Supreme Court or of the courts of appeals, including this court." The court emphasized that fraudulent joinder should only be found in two situations: when a plaintiff has lied about jurisdictional facts or when there is no chance of success against the non-diverse defendant.
The ruling reversed the lower court's decision and remanded the cases for further proceedings. The court concluded that the lower court's inquiry into the plaintiffs' intent to pursue claims against Pennsylvania Hospital was inappropriate and exceeded the established methodology for assessing fraudulent joinder. The court's decision underscores the importance of respecting the plaintiff's choice of forum and the need for clear standards in determining jurisdictional issues.
Impact
This ruling has significant implications for the ongoing litigation involving Mead Johnson and Abbott Laboratories. By clarifying the standards for fraudulent joinder, the Seventh Circuit's decision may affect how similar cases are handled in the future. It reinforces the principle that a plaintiff's motives in joining a non-diverse defendant should not be a basis for determining fraudulent joinder, thereby preserving the plaintiff's right to choose their forum.
The ruling also highlights the challenges faced by defendants in removing cases to federal court when non-diverse parties are involved. It sets a precedent that may influence future cases involving similar jurisdictional disputes, particularly in the context of multidistrict litigation.